Nipro
Nipro Corporation manufactures medical devices, pharmaceuticals and instrument products.
Launch date
Employees
Market cap
AUD2.6b
Enterprise valuation
AUD9.0b (Public information from Sep 2024)
Share price
JPY1367.5 8086.T
Osaka Osaka Prefecture (HQ)
Financials
Estimates*
JPY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 455.6b | 494.8b | 545.2b | 586.8b | 635.8b | 668.3b | 700.7b |
% growth | 3 % | 9 % | 10 % | 8 % | 8 % | 5 % | 5 % |
EBITDA | 72.9b | 77.9b | 68.6b | 84.9b | 93.4b | 99.8b | 106.1b |
% EBITDA margin | 16 % | 16 % | 13 % | 14 % | 15 % | 15 % | 15 % |
Profit | 14.2b | 13.5b | 4.6b | 11.1b | 16.5b | 17.7b | 19.6b |
% profit margin | 3 % | 3 % | 1 % | 2 % | 3 % | 3 % | 3 % |
EV / revenue | 1.5x | 1.3x | 1.2x | 1.2x | 1.2x | 1.1x | 1.1x |
EV / EBITDA | 9.1x | 8.2x | 9.8x | 8.6x | 7.9x | 7.4x | 7.0x |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
Total Funding | - |
Recent News about Nipro
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.